Toyota|$17.78 (¥2,850)+0.41%▲ (in JPY terms)
Sony|$22.20 (¥3,559)+0.54%▲ (in JPY terms)
SoftBank|$46.33 (¥7,426)+0.66%▲ (in JPY terms)
MUFG|$20.08 (¥3,219)+1.58%▲ (in JPY terms)
Keyence|$487.05 (¥78,070)-2.46%▼ (in JPY terms)
Nintendo|$46.94 (¥7,524)+3.47%▲ (in JPY terms)
NTT|$0.91 (¥146)-0.61%▼ (in JPY terms)
Takeda|$30.73 (¥4,926)+1.57%▲ (in JPY terms)
Tokyo Electron|$370.88 (¥59,450)-6.61%▼ (in JPY terms)
Recruit|$66.10 (¥10,595)-0.19%▼ (in JPY terms)
ITOCHU|$11.69 (¥1,874)+1.02%▲ (in JPY terms)
Honda|$9.01 (¥1,445)-3.99%▼ (in JPY terms)
Shin-Etsu|$45.85 (¥7,350)-3.81%▼ (in JPY terms)
Tokio Marine|$43.65 (¥6,996)+0.81%▲ (in JPY terms)
Fast Retailing|$490.98 (¥78,700)-0.22%▼ (in JPY terms)
Toyota|$17.78 (¥2,850)+0.41%▲ (in JPY terms)
Sony|$22.20 (¥3,559)+0.54%▲ (in JPY terms)
SoftBank|$46.33 (¥7,426)+0.66%▲ (in JPY terms)
MUFG|$20.08 (¥3,219)+1.58%▲ (in JPY terms)
Keyence|$487.05 (¥78,070)-2.46%▼ (in JPY terms)
Nintendo|$46.94 (¥7,524)+3.47%▲ (in JPY terms)
NTT|$0.91 (¥146)-0.61%▼ (in JPY terms)
Takeda|$30.73 (¥4,926)+1.57%▲ (in JPY terms)
Tokyo Electron|$370.88 (¥59,450)-6.61%▼ (in JPY terms)
Recruit|$66.10 (¥10,595)-0.19%▼ (in JPY terms)
ITOCHU|$11.69 (¥1,874)+1.02%▲ (in JPY terms)
Honda|$9.01 (¥1,445)-3.99%▼ (in JPY terms)
Shin-Etsu|$45.85 (¥7,350)-3.81%▼ (in JPY terms)
Tokio Marine|$43.65 (¥6,996)+0.81%▲ (in JPY terms)
Fast Retailing|$490.98 (¥78,700)-0.22%▼ (in JPY terms)

TERUMO CORPORATION (4543)

TSE 4543 · Precision Instruments

TERUMO CORPORATION

テルモ株式会社
$14.22 (¥2,280)
-65.5 (-2.79%)in JPY terms
Delayed quote · Yahoo Finance
🏢 Industry: Precision Instruments
🌐 ISIN: JP3546800008
📊 TSE: 4543
Company Overview

Terumo is one of Japan's leading medical device manufacturers, producing a comprehensive range of products including catheters, blood transfusion systems, surgical devices, and diabetes care equipment. The company serves healthcare providers across hospitals, clinics, and home care settings, with operations spanning Asia, the Americas, and Europe.

For international investors, Terumo offers meaningful exposure to the growing global medical device industry, underpinned by aging demographics and increasing healthcare utilization across both developed and emerging markets. The company's cardiovascular and interventional systems businesses are particularly well positioned to benefit from rising demand for minimally invasive cardiac procedures, while its established global sales network provides a stable platform for continued international expansion.

Recent Press Releases
2026-06-022026-06-01 TERUMO CORPORATION “Voluntary recall of certain varieties of the "RelayPro" thoracic stent graft system (PDF 696.12 KB).”2026-05-212026-05-20 TERUMO CORPORATION “Terumo Group's Vasquetech has received the King's Award (Corporate Category) in recognition of its custom-made approach to hybrid products.”2026-05-192026-05-18 TERUMO CORPORATION “Terumo's blood glucose management app, "Medisafe DataShare," has begun app integration with "Oishii Kenko" (Delicious Health). By combining blood glucose measurement and recording with meal selection suggestions, it will further support the lives of people with diabetes.”2026-05-162026-05-15 TERUMO CORPORATION “Notice Regarding the Appointment of Directors (PDF 386.79 KB).”2026-05-152026-05-14 TERUMO CORPORATION “Notice regarding personnel changes (department heads) (PDF 302.06 KB).”2026-05-012026-04-30 TERUMO CORPORATION “Terumo issues unsecured US dollar-denominated ordinary corporate bonds (5-year bonds, US$500 million) (PDF 465.71 KB).”2026-04-292026-04-28 TERUMO CORPORATION “Terumo supports "Nursing Day and Nursing Week" in 2026.”2026-04-282026-04-27 TERUMO CORPORATION “Regarding the naming of OrganOx's business operations and changes to its disclosed segments.”2026-04-282026-04-27 TERUMO CORPORATION “Terumo launches thermometer that can measure temperature in about 10 seconds, supporting people's daily lives through temperature checks.”2026-04-142026-04-13 TERUMO CORPORATION “Terumo's abdominal aortic stent graft "Fenestrated TREO" has received Breakthrough Device designation from the U.S. FDA.”
Key Data
52W High
$17.58 (¥2,818)
52W Low
$11.85 (¥1,900)
TSE Code
4543
ISIN
JP3546800008